期刊文献+

白藜芦醇-羟丙基-β-环糊精-壳聚糖缓释微球的制备及表征 被引量:3

Preparation and Quality Evaluation of Resveratrol-Hydroxypropyl-β-Cyclodextrin-Chitosan Sustainedrelease Pellets
下载PDF
导出
摘要 目的:制备白藜芦醇(RES)-羟丙基-β-环糊精(HP-β-CD)-壳聚糖缓释微球(RES-HP-β-CD-Chitosan),并进行表征。方法:按质量比1∶7∶0.25称取RES原料药、HP-β-CD和壳聚糖,先采用溶剂法制备RES-HP-β-CD包合物,在此基础上加入壳聚糖,采用喷雾干燥法制得RES-HP-β-CD-Chitosan。采用光学显微镜观察所制缓释微球的粒径。采用X射线衍射法、差式扫描量热法、红外光谱法、扫描电子显微镜对所制RES-HP-β-CD-Chitosan进行表征。采用紫外分光光度法测定所制缓释微球中RES的含量,计算载药量和包封率。结果:所制RES-HP-β-CD-Chitosan的粒径为(2.23±0.35)μm(n=300),表征结果显示,RES-HP-β-CDChitosan呈球形,微球表面出现收缩褶皱,RES被包合于羟丙基-β-环糊精中,以分子状态或无定型状态存在。RES-HP-β-CD-Chitosan的载药量为11.67%(n=3)、包封率为96.27%(n=3)。结论:成功制得RES-HP-β-CD-Chitosan。 OBJECTIVE:To prepare Resveratrol-hydroxypropyl-β-cyclodextrin-chitosan sustained-release pellets (RES-HP-β- CD-Chitosan),and to characterize it. METHODS:Resveratrol raw material,HP-β-cyclodextrin and chitosan were collected with ratio of 1 ∶ 7 ∶ 0.25. Resveratrol-HP-β-cyclodextrin inclusion compound were prepared by solvent method,and then added into chitosan,RES-HP-β-CD-Chitosan were prepared by spray drying method. Particle size of prepared sustained-released pellets were observed by optical microscope. X-ray,DSC,IR and SEM were used to characterize RES-HP-β-CD-Chitosan. The contents of resveratrol in prepared sustained-released pellets were determined by UV spectrum,and drug-loading amount and encapsulation efficiency were calculated. RESULTS:Particle size of prepared RES-HP-β-CD-Chitosan was (2.23 ± 0.35)μm(n=300). Characterization results show that RES-HP-β-CD-Chitosan was spherical in shape;shrinkage was found on the surface of microspheres,and resveratrol was included in HP-β-cyclodextrin in molecule or amorphous state. Drug-loading amount of prepared RES-HP-β-CD-Chitosan was 11.67%(n=3),encapsulation efficiency was 96.27%(n=3). CONCLUSIONS:RES-HP-β-CDChitosan is prepared successfully.
作者 张纯刚 于琛琛 周旖璇 尹丽 程岚 康廷国 韩岚 ZHANG Chungang;YU Chenchen;ZHOU Yixuan;YIN Li;CHENG Lan;KANG Tingguo;HAN Lan(School of Pharmacy,Liaoning University of Traditional Chinese Medicine,Liaoning Dalian 116620,China;School of Pharmacy,Anhui University of Traditional Chinese Medicine,Hefei 230012,China)
出处 《中国药房》 CAS 北大核心 2019年第17期2322-2326,共5页 China Pharmacy
基金 国家自然科学基金资助项目(No.81503257) 国家重点研发计划课题(No.2018YFC1706903) 辽宁省博士科研启动基金计划立项项目(No.201501098)
关键词 白藜芦醇 羟丙基-Β-环糊精 壳聚糖 制备 表征 Resveratrol Hydroxypropyl-β-cyclodextrin Chitosan Preparation Characterization
  • 相关文献

参考文献6

二级参考文献79

  • 1李沙,侯新朴.海藻酸钠-壳聚糖微囊成型机理及其对大分子药物的载药、释药研究[J].药学学报,2003,38(5):380-383. 被引量:36
  • 2GUERRERO R F, GARCíA-PARRILLA M C, PUERTAS B, et al. Wine, resveratrol and health: A review . Nat Prod Commun, 2009,4(5):635-658.
  • 3GIN G S. The protective effect of resveratrol on rat brain after focal ischemia .中国药学杂志, 2012,47(5):393-394.
  • 4WALLE T, HSIEH F, DELEGGE M H, et al. High absorption but very low bioavailability of oral resveratrol in humans . Drug Metab Dispos, 2004,32(12):1377-1382.
  • 5GESCHER A J, STEWARD W P. Relationship between mechanisms, bioavailibility, and preclinical chemopreventive efficacy of resveratrol: A conundrum . Cancer Epidemiol Biomarkers Prev, 2003,12(10):953-957.
  • 6NAULI A M, NAULI S M. Intestinal transport as a potential determinant of drug bioavailability . Curr Clin Pharmacol, 2012 Dec 31.
  • 7JOANA M. PLANAS, IRENE ALFARAS, HELENA COLOM, et al. The bioavailability and distribution of trans-resveratrol are constrained by ABC transporters . Archives of Biochemistry and Biophysics, 2012,527(2):67-73.
  • 8LAN ON A, HANET N, JANNIN B, et al. Resveratrol in human hepatoma HepG2 cells: Metabolism and inducibility of detoxifying enzymes . Drug Metab Dispos, 2007,35 (5):699-703.
  • 9MURIAS M, MIKSITS M, AUST S, et al. Metabolism of resveratrol in breast cancer cell lines: Impact of sulfotransferase 1A1 expression on cell growth inhibition . Cancer Lett, 2008, 261(2):172-182.
  • 10MAIER-SALAMON A, HAGENAUER B, WIRTH M, et al. Increased transport of resveratrol across monolayers of the human intestinal Caco-2 cells is mediated by inhibition and saturation of metabolites . Pharm Res, 2006,23(9):2107-2015.

共引文献35

同被引文献22

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部